SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017983
Filing Date
2019-05-09
Accepted
2019-05-09 16:11:34
Documents
74
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q svra-10q_20190331.htm 10-Q 1876864
2 EX-10.1 svra-ex101_531.htm EX-10.1 287900
3 EX-31.1 svra-ex311_7.htm EX-31.1 14782
4 EX-31.2 svra-ex312_6.htm EX-31.2 14534
5 EX-32.1 svra-ex321_8.htm EX-32.1 10688
  Complete submission text file 0001564590-19-017983.txt   7869709

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT svra-20190331.xml EX-101.INS 1689943
7 XBRL TAXONOMY EXTENSION SCHEMA svra-20190331.xsd EX-101.SCH 71399
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE svra-20190331_cal.xml EX-101.CAL 53715
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE svra-20190331_def.xml EX-101.DEF 199742
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20190331_lab.xml EX-101.LAB 484945
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20190331_pre.xml EX-101.PRE 356611
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 19810645
SIC: 2834 Pharmaceutical Preparations